Acadian Asset Management Portfolio holdings
AUM
$48.4B
1-Year Return
32.04%
This Quarter Return
+13.47%
1 Year Return
+32.04%
3 Year Return
+133.69%
5 Year Return
+272.69%
10 Year Return
+761.99%
AUM
$48.4B
AUM Growth
+$13.1B
(+37%)
Cap. Flow
+$9.2B
Cap. Flow
% of AUM
19%
Top 10 Holdings %
Top 10 Hldgs %
22.94%
Holding
1,878
New
276
Increased
655
Reduced
560
Closed
216
Top Buys
| 1 |
NVIDIA
NVDA
|
+$651M |
| 2 |
Microsoft
MSFT
|
+$557M |
| 3 |
Salesforce
CRM
|
+$509M |
| 4 |
Apple
AAPL
|
+$405M |
| 5 |
Mastercard
MA
|
+$304M |
Top Sells
| 1 |
Spotify
SPOT
|
+$436M |
| 2 |
Barclays
BCS
|
+$202M |
| 3 |
On Holding
ONON
|
+$186M |
| 4 |
Philip Morris
PM
|
+$142M |
| 5 |
Citigroup
C
|
+$132M |
Sector Composition
| 1 | Technology | 34.96% |
| 2 | Communication Services | 14.74% |
| 3 | Financials | 13.4% |
| 4 | Healthcare | 10.58% |
| 5 | Consumer Discretionary | 9.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Churchill Downs
CHDN
$6.89B
| $742K | ﹤0.01% |
+7,347
| New | +$742K |
|
1052
Turkcell
TKC
$4.72B
| $740K | ﹤0.01% |
122,395
-59,406
| -33% | -$359K |
|
1053
Occidental Petroleum
OXY
$45.4B
| $737K | ﹤0.01% |
17,563
-8,459
| -33% | -$355K |
|
1054
Aldeyra Therapeutics
ALDX
$331M
| $735K | ﹤0.01% |
192,402
+96,442
| +101% | +$368K |
|
1055
FibroGen
FGEN
$50.3M
| $735K | ﹤0.01% |
139,121
-17,093
| -11% | -$90.3K |
|
1056
SpartanNash
SPTN
$897M
| $735K | ﹤0.01% |
+27,813
| New | +$735K |
|
|
MRP
1057
Millrose Properties, Inc.
MRP
$5.75B
| $732K | ﹤0.01% |
+25,715
| New | +$732K |
|
1058
Performance Shipping
PSHG
$23.6M
| $731K | ﹤0.01% |
418,572
| – | – |
|
1059
Rocket Pharmaceuticals
RCKT
$345M
| $728K | ﹤0.01% |
+297,905
| New | +$728K |
|
1060
RAPT Therapeutics
RAPT
$264M
| $726K | ﹤0.01% |
91,075
+9,905
| +12% | +$79K |
|
1061
Xencor
XNCR
$593M
| $726K | ﹤0.01% |
+92,614
| New | +$726K |
|
1062
Monro
MNRO
$528M
| $722K | ﹤0.01% |
+48,461
| New | +$722K |
|
1063
Xperi
XPER
$277M
| $705K | ﹤0.01% |
+89,306
| New | +$705K |
|
1064
Backblaze
BLZE
$529M
| $700K | ﹤0.01% |
+127,466
| New | +$700K |
|
1065
Harmony Biosciences
HRMY
$1.9B
| $699K | ﹤0.01% |
22,177
-116,298
| -84% | -$3.67M |
|
1066
BP
BP
$88.6B
| $696K | ﹤0.01% |
23,295
+7,106
| +44% | +$212K |
|
1067
Ovid Therapeutics
OVID
$91M
| $693K | ﹤0.01% |
2,108,336
+20,290
| +1% | +$6.67K |
|
1068
Duke Energy
DUK
$95.2B
| $692K | ﹤0.01% |
5,873
+4,108
| +233% | +$484K |
|
1069
Cooper Companies
COO
$13.3B
| $691K | ﹤0.01% |
9,718
+8,998
| +1,250% | +$640K |
|
1070
Alpha Pro Tech
APT
$51.6M
| $688K | ﹤0.01% |
147,003
-1,570
| -1% | -$7.35K |
|
1071
Actinium Pharmaceuticals
ATNM
$51.8M
| $687K | ﹤0.01% |
491,943
-12,095
| -2% | -$16.9K |
|
1072
Weyco Group
WEYS
$290M
| $686K | ﹤0.01% |
20,729
| – | – |
|
1073
CrossAmerica Partners
CAPL
$786M
| $683K | ﹤0.01% |
32,756
+10,848
| +50% | +$226K |
|
1074
FedEx
FDX
$53.7B
| $679K | ﹤0.01% |
3,002
-878
| -23% | -$199K |
|
1075
Janus Henderson
JHG
$7.05B
| $678K | ﹤0.01% |
17,498
-2,126
| -11% | -$82.4K |
|